Your session is about to expire
Sporanox vs Ketoconazole
Introduction
For patients battling fungal infections, certain antifungal medications can help in eliminating the infection and managing symptoms. Sporanox (Itraconazole) and Ketoconazole are two such drugs that are commonly prescribed for dealing with these conditions. Both of them obstruct the synthesis of ergosterol, a key component in fungal cell membranes, leading to an accumulation of precursors and causing cell death. Sporanox is a triazole antifungal agent often used in more serious systemic infections due to its broad-spectrum activity against most strains of fungi including Aspergillus and Candida species. On the other hand, Ketoconazole which belongs to imidazoles class has a narrower spectrum but still effective against dermatophytes like Trichophyton or Epidermophyton as well as yeast like Malassezia furfur responsible for dandruff or seborrheic dermatitis.
Sporanox vs Ketoconazole Side By Side
| Attribute | Sporanox | Ketoconazole |
|---|---|---|
| Brand Name | Sporanox | Ketoconazole |
| Contraindications | Liver damage symptoms, taking certain kinds of drugs like HMG-CoA reductase inhibitors (statins) or certain benzodiazepines. | Liver damage symptoms, taking certain kinds of drugs like HMG-CoA reductase inhibitors (statins) or certain benzodiazepines. |
| Cost | The price for 10 capsules of Sporanox (100 mg) averages around $200. Generic versions cost approximately between $0.75 and $5 per capsule. | The price for 30 tablets of Ketoconazole (200 mg) averages around $70. Generic versions typically range from about $.40 up to around $.90 per tablet. |
| Generic Name | Itraconazole | Ketoconazole |
| Most Serious Side Effect | Severe allergic reaction or skin reaction, vision problems, cardiovascular issues, low potassium levels, nervous system reactions. | Allergic reactions, nausea leading to vomiting, dizziness or fainting, irregular heartbeat, serious skin reactions. |
| Severe Drug Interactions | Significant interactions with multiple drugs due to potent inhibition of cytochrome P450 enzymes involved in drug metabolism. | Can interact with many other medications due to its strong inhibition on liver enzymes responsible for drug metabolism. |
| Typical Dose | Oral dosages range from 200–400 mg/day, with 200 mg/day being sufficient for treating most fungal infections in adults. | Treatment typically begins with a dose of 200-400 mg per day, adjusted based on the patient's response to the medication. |
What is Sporanox?
Itraconazole (the generic name for Sporanox) was a significant advancement from the earlier class of antifungal drugs, such as Ketoconazole. Itraconazole was first approved by the FDA in 1992. It works by preventing fungi from producing a substance called ergosterol, which is an essential component of fungal cell membranes. The disruption in production results in holes appearing in these membranes, thereby killing the fungi or preventing their growth and spread.
Sporanox is prescribed for treating various types of fungal infections that can invade any part of the body including lungs, mouth/throat, toenails, and fingernails. Unlike Ketoconazole that has effects on human steroid synthesis leading to side effects like gynecomastia and adrenal insufficiency, Itraconazole selectively inhibits fungal sterol synthesis with minimal effect on human cholesterol biosynthesis resulting in fewer side effects than other antifungals having stronger impacts on human steroids.
What conditions is Sporanox approved to treat?
Sporanox is approved for the treatment of a variety of fungal infections, such as:
- Blastomycosis, which is caused by the fungus Blastomyces dermatitidis
- Histoplasmosis, an infection that occurs from inhaling the spores of a fungus often found in bird and bat droppings
- Onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium)
- Aspergillosis in patients who are intolerant to or who are refractory to amphotericin B therapy.
How does Sporanox help with these illnesses?
Sporanox, or itraconazole, is an antifungal medication that works by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes. It does this by binding to and inhibiting the enzyme lanosterol 14-alpha-demethylase in fungi. This leads to an accumulation of sterols that are toxic to the fungus and ultimately results in its death. As such, Sporanox effectively disrupts fungal growth and proliferation.
Ketoconazole operates similarly but has been associated with more severe side effects such as liver damage which may limit its use for certain patients. Both medications can be effective against a range of fungi species; however, their specific efficacy may differ depending on the particular strain involved. Therefore, when choosing between these two drugs for treating a fungal infection, factors like patient health history and specifics about the infection should also be considered along with potential side effects.
What is Ketoconazole?
Ketoconazole, sold under the brand name Nizoral among others, is an antifungal medication used to treat various types of fungal infections. It increases cellular permeability causing fungal cell death and was first approved by the FDA in 1981. Ketoconazole works by inhibiting the enzyme lanosterol 14 α-demethylase that fungi use to synthesize ergosterol, a vital component of their cell membranes. Without it, holes appear in the membrane leading to leakage and death of the fungus.
Unlike Sporanox (Itraconazole), which also belongs to a group of drugs known as azole antifungals but has less drug-interaction concerns than ketoconazole, Ketoconazole can interact with many other medications due its strong inhibition on liver enzymes responsible for drug metabolism. Its side-effect profile is different from that of Sporanox; common side effects include nausea and itchiness while rare side effects include liver problems or worsening asthma symptoms. The effect on fungi's ability to synthesize ergosterol can be beneficial for treating certain kinds of fungal infections especially those unresponsive or resistant to other similar treatments such as Sporanox.
What conditions is Ketoconazole approved to treat?
Ketoconazole is a potent antifungal medication that's been approved for the treatment of several conditions including:
- Systemic fungal infections, such as candidiasis, coccidioidomycosis, histoplasmosis and paracoccidioidomycosis
- Chronic mucocutaneous candidiasis
- Tinea (pityriasis) versicolor. Please note that Ketoconazole should only be used when other effective antifungal therapy is not available or tolerated.
How does Ketoconazole help with these illnesses?
Ketoconazole, like Sporanox (generic name itraconazole), is an antifungal medication that works by interfering with the formation of the fungal cell membrane. It actively prevents the growth and replication of a wide variety of fungi by altering their cellular infrastructure, thereby stopping infection in its tracks. Ketoconazole primarily acts on ergosterol synthesis, which is crucial for maintaining the integrity and function of the fungal cytoplasmic membrane. Its broad-spectrum activity makes it particularly useful in treating many different types of fungal infections, including those caused by Candida species and Malassezia furfur which are resistant to other antifungals. While Sporanox also targets ergosterol synthesis, patients who do not respond well to it or suffer from certain side effects might find ketoconazole to be a suitable alternative.
How effective are both Sporanox and Ketoconazole?
Both itraconazole (Sporanox) and ketoconazole are antifungal drugs commonly used to treat a variety of fungal infections. They were both approved by the FDA, with ketoconazole being introduced in 1981 and itraconazole later in 1992. These medications function by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes, thereby disrupting fungal growth.
The effectiveness of itraconazole and ketoconazole was directly compared in several studies which showed that they have similar efficacy in treating various forms of fungal infections such as candidiasis and tinea infections. However, these two drugs have different safety profiles; while both can cause liver damage, this side effect is more common with ketoconazole use.
A review on oral antifungals published in The American Journal Of Clinical Dermatology noted that itraconazole exhibits greater bioavailability than ketoconazale due to its ability to be absorbed regardless food intake unlike ketoconaole which requires an acidic environment for proper absorption - often necessitating administration with cola or fruit juice. Itraconzaole also has a broader spectrum activity compared to ketaconaole making it suitable for wide range fungual species.
Accordingly, despite their similarities, these two drugs may be chosen under different circumstances depending upon patient-specific factors such as potential drug interactions given that Ketoaconzole has been found to interact significantly with multiple drugs due its potent inhibition cytochrome P450 enzymes involved in drug metabolism.
In terms of tolerability profile; although both medication can result into distressing gastrointestinal symptoms- nausea vomiting or abdominal pain-, Itrocanzole is generally better tolerated than Ketaoconsle which carries additional risk including adrenal insufficiency especially when used systemically at high doses for prolonged period.
Therefore ,while Sporanox (itraocanzol) might be considered a second-generation medication offering some advantages over Ketoconoalez regarding usage flexibility,broad-spectrum coverage against fungi,and lower interaction potential ;Ketoconcnaozle remains valuable treatment option especially topically where systemic exposure minimal hence lowering associated risks .
Related trials for sporanox and ketoconazole
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Sporanox typically prescribed?
Oral dosages of Sporanox range from 200–400 mg/day, but studies have indicated that 200 mg/day is sufficient for treating most fungal infections in adults. The dose may be divided into two doses of 100 mg each or taken as a single dose of 200mg depending on the specific infection being treated. Children's dosage should be determined by their doctor. In either population, dosage can be adjusted after a few weeks if there is no response. The maximum daily dosage that should not be exceeded in any case is 400 mg/day.
On the other hand, oral dosages of Ketoconazole range from 200 to 400mg per day for adults with severe systemic fungal infections. For children, the dose varies and will depend on their weight; generally speaking it ranges between 3.3 –6.6 mg/kg per day . If an adequate response has not been reached after several weeks or months, your doctor may decide to increase your dose up to a maximum of 800mg/day (for very severe cases). Always consult with your healthcare provider before making changes to prescribed medications.
At what dose is Ketoconazole typically prescribed?
Ketoconazole treatment typically begins with a dose of 200-400 mg per day. The dosage can then be adjusted based on the patient's response to the medication, and severe infections may require an increase in dosage up to 400 mg/day, taken as a single dose or divided into two doses, spaced about 12 hours apart. If there is no clear improvement after several weeks at this level, your healthcare provider might consider increasing the daily dose further while closely monitoring for side effects. It's vital that patients adhere strictly to their prescribed dosing schedule even if symptoms seem to improve before completing the course of treatment.
What are the most common side effects for Sporanox?
Some of the most common side effects associated with Sporanox and Ketoconazole include:
- Nausea, vomiting
- Diarrhea, constipation
- Abdominal pain, dyspepsia (burning sensation in the stomach)
- Headache
- Dizziness
- Rash or itching
- Changes in taste
- Dry mouth or unusual thirst
- Sweating
- Fatigue or weakness In addition to these common side effects, there are also serious adverse reactions such as hepatotoxicity (liver damage), which may occur. Always consult your healthcare provider for advice about any symptoms you experience while taking these medications.
Are there any potential serious side effects for Sporanox?
While both Sporanox and Ketoconazole are antifungal medications, they can potentially cause different side effects. In rare cases, taking Sporanox could lead to:
- Severe allergic reaction or skin reaction: symptoms may include hives, difficulty breathing, swelling in your face or throat, fever, sore throat, burning eyes, skin pain or a red/purple skin rash that blisters and peels
- Vision problems: this might manifest as blurred vision, tunnel vision, eye pain or swelling; you might also see halos around lights
- Cardiovascular issues: be aware of fast/pounding heartbeats in your chest area. You may also feel shortness of breath and sudden dizziness (feeling like you're about to faint)
- Low potassium levels - watch out for leg cramps or irregular heartbeat
- Nervous system reactions - muscle weakness/spasms very stiff muscles (rigid), high fever sweating confusion fast/uneven heartbeat tremors feeling like you might pass out.
Meanwhile with Ketoconazole:
- Allergic reactions such as itching/swelling especially of the face/tongue/throat severe dizziness trouble breathing.
- New signs of infection e.g., fever persistent sore throat). -Easy bruising/bleeding unusual tiredness. -Signs of adrenal gland problems such as unusually tired shaking chills loss of appetite mental/mood changes weight loss severe nausea/vomiting diarrhea/stomach pain darkening skin color headache increased thirst frequent urination
In either case if these symptoms persist it's important to seek medical help immediately
What are the most common side effects for Ketoconazole?
Ketoconazole, similar to Sporanox, can have its own side effects including:
- Nausea and vomiting
- Stomach pain or discomfort
- Diarrhea
- Headache
- Dizziness or a feeling of unsteadiness
- Changes in menstrual periods for women
- Impotence or loss of interest in sexual intercourse (in men)
As with any medication, it's important to note that not everyone will experience all these side effects. However, if you're experiencing persistent negative symptoms on this medicine, it's wise to consult your healthcare provider promptly.
Are there any potential serious side effects for Ketoconazole?
Ketoconazole is generally a safe medication, but like any drug, it may cause some side effects. Severe adverse reactions are rare and usually occur in response to high doses or extended use of the drug. These can include:
- Signs of an allergic reaction such as hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
- Nausea leading to vomiting
- Dizziness or fainting
- Irregular heartbeat
- Serious skin reactions - fever, sore throat, swelling in your face or tongue, burning in your eyes followed by skin pain culminating into red/purple skin rash that spreads (especially in the face or upper body) causing blistering and peeling.
If you experience these symptoms while taking Ketoconazole stop using this medicine immediately and seek medical attention promptly.
Contraindications for Sporanox and Ketoconazole?
Both Sporanox and Ketoconazole, along with most other antifungal medications, can cause liver damage in some people. If you notice symptoms such as fatigue, loss of appetite, dark urine or jaundice (yellowing of the skin/eyes), please seek immediate medical attention.
Neither Sporanox nor Ketoconazole should be taken if you are taking certain kinds of drugs like HMG-CoA reductase inhibitors also known as statins (drugs that reduce cholesterol levels) or certain benzodiazepines which are used to treat anxiety and insomnia. Always inform your physician about any medications you're currently using; these aforementioned drugs may interact harmfully with both Sporanox and Ketoconazole leading to serious side effects such as muscle breakdown leading to kidney damage in case of statins or excessive sedation and respiratory depression in case of benzodiazepines.
How much do Sporanox and Ketoconazole cost?
For the brand-name versions of these medications:
- The price for 10 capsules of Sporanox (100 mg) averages around $200, which works out to about $20 per day.
- The price for 30 tablets of Ketoconazole (200 mg) averages around $70, which equates to roughly $2.33 per day.
Therefore, if you're prescribed a daily dose, then Ketoconazole is less expensive on a per-day treatment basis than Sporanox. But it's crucial to remember that cost should not be your main consideration in choosing between these two antifungal drugs; effectiveness and potential side effects are also important considerations.
In terms of generic versions:
-
Itraconazole (generic version of Sporanox), available in packs from 14 up to 500 capsules, costs approximately between $0.75 and $5 per capsule depending on pack size and pharmacy pricing variability.
-
Generic ketoconazole is more affordable with prices typically ranging from as low as about $.40 up to around $.90 per tablet.
Remember that the actual cost can vary based on factors like where you live, where you shop for medication, and whether or not you have health insurance coverage.
Popularity of Sporanox and Ketoconazole
Itraconazole, available under the brand name Sporanox, and ketoconazole are both antifungal drugs used to treat a variety of fungal infections.
In 2020, itraconazole was prescribed to an estimated 1.6 million people in the US, accounting for roughly 13% of prescriptions for systemic antifungals. This drug has steadily grown in popularity since its introduction due to its broad spectrum activity against many types of fungi.
Ketoconazole is older than itraconazole and was once widely used as a first-line treatment for certain serious fungal infections. However, due to concerns about liver toxicity and interactions with other medications, its use has declined dramatically over time. In fact, oral ketoconazole is no longer available in many countries including the United States except under very specific circumstances where potential benefits are considered to outweigh risks. Topical formulations such as creams and shampoos remain widely used though; they were prescribed around 4 million times in the USA during 2020.
Conclusion
Both Sporanox (itraconazole) and ketoconazole are antifungal medications that have a long history of use in the treatment of various fungal infections. They work by inhibiting the production of ergosterol, an essential component of fungal cell walls, thereby disrupting their growth and replication. Both drugs can be used together under careful supervision from a healthcare provider as they can interact with each other.
Sporanox is generally considered more potent than ketoconazole and has a broader spectrum of activity against different types of fungi. It's typically reserved for serious systemic infections or when other antifungals fail to yield results.
Ketoconazole, on the other hand, was once widely prescribed for systemic fungal infections but now is mostly used topically due to potential liver toxicity associated with oral administration.
Both drugs are available in generic forms which significantly reduces costs for patients who pay out-of-pocket. The effects may not be noticeable immediately as it takes some time for these drugs to effectively combat the infection.
The side effect profiles between these two medications differ; while both have potential gastrointestinal side effects like nausea and vomiting, ketoconazole carries more severe risks such as hepatotoxicity. Patients must closely monitor any changes in health during treatment with either drug and should seek immediate medical help if they notice signs indicating liver problems such as fatigue, loss of appetite or yellowing eyes/skin.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Grant, S. M., & Clissold, S. P. (1989, March). Itraconazole. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-198937030-00003
- Caputo, R. (2003, December). Itraconazole (Sporanox®) in superficial and systemic fungal infections. Expert Review of Anti-infective Therapy. Informa UK Limited.http://doi.org/10.1586/14787210.1.4.531
- Glasmacher, A., & Prentice, A. G. (2005, September 1). Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies. Journal of Antimicrobial Chemotherapy. Oxford University Press (OUP).http://doi.org/10.1093/jac/dki221
- Van den Bossche, H., Willemsens, G., Cools, W., Cornelissen, F., Lauwers, W. F., & van Cutsem, J. M. (1980, June). In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis. Antimicrobial Agents and Chemotherapy. American Society for Microbiology.http://doi.org/10.1128/aac.17.6.922
- Smith, E. B., & Henry, J. C. (1984, July 8). Ketoconazole: An Orally Effective Antifungal Agent Mechanism of Action, Pharmacology, Clinical Efficacy and Adverse Effects. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. Wiley.http://doi.org/10.1002/j.1875-9114.1984.tb03356.x
- Borgers, M., Van den Bossche, H., & De Brabander, M. (1983, January). The mechanism of action of the new antimycotic ketoconazole. The American Journal of Medicine. Elsevier BV.http://doi.org/10.1016/0002-9343(83)90507-7
- Smith, D. E., Midgley, J., Allan, M., Connolly, G. M., & Gazzard, B. G. (1991, November). Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV. Aids. Ovid Technologies (Wolters Kluwer Health).http://doi.org/10.1097/00002030-199111000-00014
- Maksymiuk, A. W., Levine, H. B., & Bodey, G. P. (1982, July). Pharmacokinetics of ketoconazole in patients with neoplastic diseases. Antimicrobial Agents and Chemotherapy. American Society for Microbiology.http://doi.org/10.1128/aac.22.1.43
- Svedhem, Å. (1984, January). Toxic Hepatitis Following Ketoconazole Treatment. Scandinavian Journal of Infectious Diseases. Informa UK Limited.http://doi.org/10.3109/00365548409068418